BIOWAMED Trademark

Trademark Overview


On Friday, February 14, 2003, a trademark application was filed for BIOWAMED with the United States Patent and Trademark Office. The USPTO has given the BIOWAMED trademark a serial number of 78214938. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, March 15, 2006. This trademark is owned by Kyowa Hakko Kogyo Co., Ltd.. The BIOWAMED trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Biochemicals, namely, monoclonal antibodies, fragments of such antibodies and derivatives of such antibodies for in vitro scientific or research use; cells for scientific, laboratory or medical research cells that manufacture antibody, fragment of antibody or derivatives of antibody; cells for scientific, laboratory or medical research, namely, transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; host cells for scientific, laboratory or medical research

Cells for medical or clinical use that manufacture antibodies, fragments of antibodies or derivatives of antibodies; cells for medical or clinical use, namely, transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; host cells for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined o...

Custom manufacturing of antibodies, fragments of such antibodies and derivatives of such antibodies; custom manufacturing of cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; custom manufacturing of transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; custom manufacturing of host cells

Contract development of antibodies, fragments of such antibodies and derivatives of such antibodies; contract development of cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; contract development of transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; contract development of host cells

General Information


Serial Number78214938
Word MarkBIOWAMED
Filing DateFriday, February 14, 2003
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, March 15, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 22, 2004

Trademark Statements


Goods and ServicesBiochemicals, namely, monoclonal antibodies, fragments of such antibodies and derivatives of such antibodies for in vitro scientific or research use; cells for scientific, laboratory or medical research cells that manufacture antibody, fragment of antibody or derivatives of antibody; cells for scientific, laboratory or medical research, namely, transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; host cells for scientific, laboratory or medical research
Goods and ServicesCells for medical or clinical use that manufacture antibodies, fragments of antibodies or derivatives of antibodies; cells for medical or clinical use, namely, transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; host cells for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidium in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and/or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, antiparkinsonism drugs, minor tranquilizers, and antianxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, vitamins, anti-bacterial preparations, mucolytic preparations, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extracorporeal diagnostic reagents for medical use, in vitro X-ray contrast agents for medical use, in vitro diagnostic media, pharmaceutical preparations for the treatment of insomnia and other sleep related diseases
Goods and ServicesCustom manufacturing of antibodies, fragments of such antibodies and derivatives of such antibodies; custom manufacturing of cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; custom manufacturing of transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; custom manufacturing of host cells
Goods and ServicesContract development of antibodies, fragments of such antibodies and derivatives of such antibodies; contract development of cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; contract development of transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; contract development of host cells

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateNOT AVAILABLE
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 7, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, March 7, 2003
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateNOT AVAILABLE
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKyowa Hakko Kogyo Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo
JP

Party NameKyowa Hakko Kogyo Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo
JP

Trademark Events


Event DateEvent Description
Tuesday, May 16, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, May 16, 2006ABANDONMENT - NO USE STATEMENT FILED
Friday, April 7, 2006APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 7, 2006PAPER RECEIVED
Wednesday, September 7, 2005EXTENSION 2 GRANTED
Wednesday, September 7, 2005EXTENSION 2 FILED
Wednesday, September 7, 2005TEAS EXTENSION RECEIVED
Tuesday, April 19, 2005EXTENSION 1 GRANTED
Thursday, March 10, 2005EXTENSION 1 FILED
Thursday, March 10, 2005TEAS EXTENSION RECEIVED
Tuesday, September 14, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 22, 2004PUBLISHED FOR OPPOSITION
Wednesday, June 2, 2004NOTICE OF PUBLICATION
Wednesday, April 14, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 17, 2004ASSIGNED TO EXAMINER
Tuesday, March 2, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 2, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 3, 2004ASSIGNED TO EXAMINER
Monday, February 9, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 9, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 12, 2003NON-FINAL ACTION MAILED
Monday, August 11, 2003ASSIGNED TO EXAMINER